Recent Declines in Hospitalizations for Acute Myocardial Infarction for Medicare Fee-for-Service Beneficiaries

Chen, Jersey; Normand, Sharon‐Lise T.; Wang, Yun; Drye, Elizabeth E.; Schreiner, Geoffrey C.; Krumholz, Harlan M.

doi:10.1161/circulationaha.109.862094

Cited by 141 publications

(126 citation statements)

References 40 publications

Supporting

Mentioning

113

Contrasting

Unclassified

Order By: Relevance

“…Despite the declining incidence of CHD in the USA reported in the former section of this article, many (26,(39)(40)(41), but not all (42,43), observational studies have found no reduction in the incidence of MI in a variety of time periods including 1971-1982 and 1982-1992 (26), 1975-1997 (39), 1994-1999 (40), and 1987-2006 (43). In a study of 5,832 Massachusetts patients with acute MI seen between 1975 and 1997, the incidence of MI was similar in 1975-1978 and 1997, respectively (230 per 100,000 people in both periods) (39).…”

Section: What About Mi?mentioning

confidence: 67%

Epidemiology of coronary heart disease and acute coronary syndrome

Sanchís-Gomar¹,

Pérez-Quilis²,

Leischik³

et al. 2016

Ann. Transl. Med.

995

617

View full text Add to dashboard Cite

The aim of this review is to summarize the incidence, prevalence, trend in mortality, and general prognosis of coronary heart disease (CHD) and a related condition, acute coronary syndrome (ACS). Although CHD mortality has gradually declined over the last decades in western countries, this condition still causes about one-third of all deaths in people older than 35 years. This evidence, along with the fact that mortality from CHD is expected to continue increasing in developing countries, illustrates the need for implementing effective primary prevention approaches worldwide and identifying risk groups and areas for possible improvement.

show abstract

Section: What About Mi?mentioning

confidence: 67%

Epidemiology of coronary heart disease and acute coronary syndrome

Sanchís-Gomar¹,

Pérez-Quilis²,

Leischik³

et al. 2016

Ann. Transl. Med.

995

617

View full text Add to dashboard Cite

show abstract

“…Even with these limitations, we still believe that our findings are important and provide internally consistent information about ACHD‐related HF hospitalizations. Similar methods have been widely used and accepted for studies of acquired HF 8, 24. We25 and others26 have reported the constraints of administrative data sets for detection and categorization of ACHD.…”

Section: Discussionmentioning

confidence: 99%

Hospitalization Trends and Health Resource Use for Adult Congenital Heart Disease–Related Heart Failure

Burchill

Gao

Kovacs

et al. 2018

JAHA

View full text Add to dashboard Cite

BackgroundThis study assessed trends in heart failure (HF) hospitalizations and health resource use in patients with adult congenital heart disease (ACHD).Methods and ResultsThe Nationwide Inpatient Sample was used to compare ACHD with non‐ACHD HF hospitalization and health resource trends. Health resource use was assessed using total hospital charges, hospital length of stay, and procedural burden. A total of 87 175±2676 ACHD‐related HF hospitalizations occurred between 1998 and 2011. During this time, ACHD HF hospitalizations increased 91% (4620±438–8809±740, P<0.0001) versus a 21% increase in non‐ACHD HF hospitalizations (P=0.003). ACHD HF hospitalization was associated with longer length of stay (ACHD HF versus non‐ACHD HF, 7.2±0.09 versus 6.8±0.02 days; P<0.0001), greater procedural burden, and higher charges ($81 332±$1650 versus $52 050±$379; P<0.0001). ACHD HF hospitalization charges increased 258% during the study period ($26 533±$1816 in 1998 versus $94 887±$8310 in 2011; P=0.0002), more than double that for non‐ACHD HF (P=0.04). Patients with ACHD HF hospitalized in high‐volume ACHD centers versus others were more likely to undergo invasive hemodynamic testing (30.2±0.6% versus 20.7±0.5%; P<0.0001) and to receive cardiac resynchronization/defibrillator devices (4.7±0.3% versus 1.8±0.2%; P<0.0001) and mechanical circulatory support (3.9±0.2% versus 2.4±0.2%; P<0.0001).Conclusions ACHD‐related HF hospitalizations have increased dramatically in recent years and are associated with disproportionately higher costs, procedural burden, and health resource use.

show abstract

“…34,35 It is notable that the opposite trend of increasing rates of AMI was observed in 35-to 54-year-old women, which has been mirrored by US AMI data over a similar time . 8 Stroke prevalence also appears to be rising faster among middle-aged women in the United States .…”

Section: Discussionmentioning

confidence: 90%

Most Important Outcomes Research Papers on Cardiovascular Disease in Women

Gupta¹,

Lampropulos²,

Bikdeli³

et al. 2013

Circ: Cardiovascular Quality and Outcomes

View full text Add to dashboard Cite

Summary: In the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial, lasofoxifene was associated with lower risk of non-vertebral fractures and estrogen-receptor-positive breast cancer .6 Authors conducted this sub-study to understand the relationship between lasofoxifene use and the occurrence of a comprehensive endpoint encompassing major CHD events including coronary death, nonfatal myocardial infarction (MI), new ischemic heart disease, hospitalization for unstable angina, or coronary revascularization . The trial randomized 8556 osteoporotic women 59 to 80 years of age to lasofoxifene 0 .25 mg/d, lasofoxifene 0 .5 mg/d or placebo for 5 years . The authors report that lasofoxifene 0 .5 mg/d reduced the risk of major

show abstract

Recent Declines in Hospitalizations for Acute Myocardial Infarction for Medicare Fee-for-Service Beneficiaries

Abstract: Background-Amid recent efforts to reduce cardiovascular risk, whether rates of acute myocardial infarction (AMI)

Cited by 141 publications

References 40 publications

Epidemiology of coronary heart disease and acute coronary syndrome

Epidemiology of coronary heart disease and acute coronary syndrome

Hospitalization Trends and Health Resource Use for Adult Congenital Heart Disease–Related Heart Failure

Most Important Outcomes Research Papers on Cardiovascular Disease in Women

Contact Info

Product

Resources

About